The eye.gnos management team worked with and for several partners in the pharma and CRO, investor and corporate world at immunology research projects and clinical programs including in inflammatory / autoimmune indications like multiple sclerosis, inflammatory bowel disease (ulcerative colitis / crohns disease), rheumatoid arthritis, lupus and other skin diseases  plus front and back of the eye indications, including:

Alcon Inc.

Allergan Inc.

Arva Ventures

Astellas

Assana

Bayer Pharma AG

Brace

Cutech Srl.

DSM Biomedical

ESBAtech

Heidelberg Engineering GmbH

Isarna Therapeutics

Kendle Inc.

Lumithera

Novartis Pharma AG

Novo Nordisk A/S

 

 

Oculis

Ophthotech Corp.

Ora

PAREXEL Int. Corp.

PPD LLC.

Regeneron Pharmaceuticals Inc.

Roche

Schering AG

Syntheract

TX Cell

Weleda AG

ZymoGenetics Inc.

 

 

... and many more.